Universal pennystocks.com focus is on Hot Penny Stocks that trade on OTCBB and OTC markets, which are mostly referred to as “penny stocks”. These Penny Stocks could offer the greatest potential return on your short or long term investment. Sign up for our free newsletter before you miss the next alert.
Scottsdale, AZ -- (SBWIRE) -- 02/01/2013 -- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares have their “sell” rating restated by TheStreet. On the other hand, analysts at Jefferies Group fixed a $14.00 price target on shares of Arena Pharmaceuticals in a research note to investors. They now have a “buy” rating on the stock.
In the last trading session, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported the gain of +4.32% and closed at $8.45 with the overall traded volume of 10.27 million shares. Stock price 52 weeks high was $13.50 and 52 weeks low price was $1.70.
Will ARNA Continue To Move Higher? Find Out Here
Gilead Sciences, Inc. (NASDAQ:GILD) will declare its latest earnings on Monday, February 4, 2013. Regardless of a projected decline in profit, analysts are mostly positive about Gilead Sciences (GILD) as it prepares to reports its fourth quarter earnings on Monday, February 4, 2013. Analysts are estimating Gilead to come in with earnings of 45 cents per share, 2.2% less than a year before when it stated earnings of 46 cents per share.
Gilead Sciences, Inc. (NASDAQ:GILD) dropped -1.00% to close at $39.45 in the last trading session and its total traded volume was 7.96 million shares. GILD has market cap of 59.78 billion.
Will GILD Reach The Bottom After Yesterday’s Correction? Find Out Here
Arca Biopharma Inc (NASDAQ:ABIO) shares surged +26.47% with the closing price of $0.863. The overall volume in the last trading session was 6.50 million shares. Its fifty two week range was $0.23-$1.15. The total market capitalization remained $13.33 million.
ABIO is ahead its 52 week low with 27.39% and its last month price volatility remained 1.96%. Its beta coefficient was 1.94 with a target price of $0.50. In its share capital ABIO has 15.96 million outstanding shares while 14.18 million shares have been floated in market. ABIO has insider ownership of 2.41% with its institutional ownership remained 20.53%. Company’s current year earnings per share grew with 46.02%.
What was the Moving Force behind ABIO On Bullish Run? Read This Research Report
Dendreon Corporation (NASDAQ:DNDN) plunged -1.51% and closed at $5.88 in the last trading session with the total traded volume of 4.96 million shares. DNDN has outstanding shares of 154.32 million and its total market cap is 907.38 million.
Will DNDN Get Buyers Even After The Recent Rally? Find Out Here
About Universal Penny Stocks
Universalpennystocks.com is an Independent Company, our focus is on small cap stocks that trade on OTCBB and OTC markets, and are mostly referred to as “penny stocks”. These are stocks that normally trade under $5 a share and could offer the greatest potential return on your short or long term investment. You must read our Disclaimer page for more information regarding conflicts of interest and the risks involved.
We try to spot stocks in all types of market conditions. In addition, we provide emerging small cap companies with profiling and investor relations services for compensation. If you believe your company is an emerging company, with a solid product, or a company that offers our members a profitable short or long term opportunity please feel free to send us an e-mail and we’ll review the company and reply to your inquiry promptly. Please provide as much information you believe we’ll need to review your request.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)